Feedback / Questions
MetaBlok (lsalt peptide) - Arch Biopartners
https://www.globenewswire.com/news-release/2025/01/08/3006138/0/en/Arch-Biopartners-Announces-Ontario-Research-Ethics-Board-Approval-to-Proceed-with-Phase-II-Trial-for-LSALT-Peptide-Targeting-Cardiac-Surgery-Associated-Acute-Kidney-Injury-CS-AKI.html
Jan 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next